Hypertension and Heart Failure Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 104 pages | ID: HC8ECAA43A9BEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Hypertension and Heart Failure Treatment in Global, including the following market information:

Global Hypertension and Heart Failure Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Hypertension and Heart Failure Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypertension and Heart Failure Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hypertension and Heart Failure Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Hypertension and Heart Failure Treatment Market Segment Percentages, By Type, 2020 (%)

• Diuretics
• Beta Blockers
• Ace Inhibitors
• Alpha Blockers
• Others

China Hypertension and Heart Failure Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Hypertension and Heart Failure Treatment Market Segment Percentages, By Application, 2020 (%)

• Men
• Women

Global Hypertension and Heart Failure Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Hypertension and Heart Failure Treatment Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Hypertension and Heart Failure Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Hypertension and Heart Failure Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Menarini Group
• Johnson & Johnson
• Lupin
• Boehringer Ingelheim
• Novartis
• Merck & Co
• AstraZeneca
• Pfizer, Inc
• Sanofi SA
• Dr. Reddy's Laboratories
• Daiichi Sankyo Company Limited

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hypertension and Heart Failure Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hypertension and Heart Failure Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HYPERTENSION AND HEART FAILURE TREATMENT OVERALL MARKET SIZE

2.1 Global Hypertension and Heart Failure Treatment Market Size: 2021 VS 2027
2.2 Global Hypertension and Heart Failure Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hypertension and Heart Failure Treatment Players in Global Market
3.2 Top Global Hypertension and Heart Failure Treatment Companies Ranked by Revenue
3.3 Global Hypertension and Heart Failure Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hypertension and Heart Failure Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Hypertension and Heart Failure Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hypertension and Heart Failure Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Hypertension and Heart Failure Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hypertension and Heart Failure Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Hypertension and Heart Failure Treatment Market Size Markets, 2021 & 2027
  4.1.2 Diuretics
  4.1.3 Beta Blockers
  4.1.4 Ace Inhibitors
  4.1.5 Alpha Blockers
  4.1.6 Others
4.2 By Type - Global Hypertension and Heart Failure Treatment Revenue & Forecasts
  4.2.1 By Type - Global Hypertension and Heart Failure Treatment Revenue, 2016-2021
  4.2.2 By Type - Global Hypertension and Heart Failure Treatment Revenue, 2022-2027
  4.2.3 By Type - Global Hypertension and Heart Failure Treatment Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hypertension and Heart Failure Treatment Market Size, 2021 & 2027
  5.1.2 Men
  5.1.3 Women
5.2 By Application - Global Hypertension and Heart Failure Treatment Revenue & Forecasts
  5.2.1 By Application - Global Hypertension and Heart Failure Treatment Revenue, 2016-2021
  5.2.2 By Application - Global Hypertension and Heart Failure Treatment Revenue, 2022-2027
  5.2.3 By Application - Global Hypertension and Heart Failure Treatment Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Hypertension and Heart Failure Treatment Market Size, 2021 & 2027
6.2 By Region - Global Hypertension and Heart Failure Treatment Revenue & Forecasts
  6.2.1 By Region - Global Hypertension and Heart Failure Treatment Revenue, 2016-2021
  6.2.2 By Region - Global Hypertension and Heart Failure Treatment Revenue, 2022-2027
  6.2.3 By Region - Global Hypertension and Heart Failure Treatment Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Hypertension and Heart Failure Treatment Revenue, 2016-2027
  6.3.2 US Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.3.3 Canada Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.3.4 Mexico Hypertension and Heart Failure Treatment Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Hypertension and Heart Failure Treatment Revenue, 2016-2027
  6.4.2 Germany Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.4.3 France Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.4.4 U.K. Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.4.5 Italy Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.4.6 Russia Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.4.7 Nordic Countries Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.4.8 Benelux Hypertension and Heart Failure Treatment Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Hypertension and Heart Failure Treatment Revenue, 2016-2027
  6.5.2 China Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.5.3 Japan Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.5.4 South Korea Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.5.5 Southeast Asia Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.5.6 India Hypertension and Heart Failure Treatment Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Hypertension and Heart Failure Treatment Revenue, 2016-2027
  6.6.2 Brazil Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.6.3 Argentina Hypertension and Heart Failure Treatment Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hypertension and Heart Failure Treatment Revenue, 2016-2027
  6.7.2 Turkey Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.7.3 Israel Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.7.4 Saudi Arabia Hypertension and Heart Failure Treatment Market Size, 2016-2027
  6.7.5 UAE Hypertension and Heart Failure Treatment Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Menarini Group
  7.1.1 Menarini Group Corporate Summary
  7.1.2 Menarini Group Business Overview
  7.1.3 Menarini Group Hypertension and Heart Failure Treatment Major Product Offerings
  7.1.4 Menarini Group Hypertension and Heart Failure Treatment Revenue in Global (2016-2021)
  7.1.5 Menarini Group Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Hypertension and Heart Failure Treatment Major Product Offerings
  7.2.4 Johnson & Johnson Hypertension and Heart Failure Treatment Revenue in Global (2016-2021)
  7.2.5 Johnson & Johnson Key News
7.3 Lupin
  7.3.1 Lupin Corporate Summary
  7.3.2 Lupin Business Overview
  7.3.3 Lupin Hypertension and Heart Failure Treatment Major Product Offerings
  7.3.4 Lupin Hypertension and Heart Failure Treatment Revenue in Global (2016-2021)
  7.3.5 Lupin Key News
7.4 Boehringer Ingelheim
  7.4.1 Boehringer Ingelheim Corporate Summary
  7.4.2 Boehringer Ingelheim Business Overview
  7.4.3 Boehringer Ingelheim Hypertension and Heart Failure Treatment Major Product Offerings
  7.4.4 Boehringer Ingelheim Hypertension and Heart Failure Treatment Revenue in Global (2016-2021)
  7.4.5 Boehringer Ingelheim Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Hypertension and Heart Failure Treatment Major Product Offerings
  7.5.4 Novartis Hypertension and Heart Failure Treatment Revenue in Global (2016-2021)
  7.5.5 Novartis Key News
7.6 Merck & Co
  7.6.1 Merck & Co Corporate Summary
  7.6.2 Merck & Co Business Overview
  7.6.3 Merck & Co Hypertension and Heart Failure Treatment Major Product Offerings
  7.6.4 Merck & Co Hypertension and Heart Failure Treatment Revenue in Global (2016-2021)
  7.6.5 Merck & Co Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Hypertension and Heart Failure Treatment Major Product Offerings
  7.4.4 AstraZeneca Hypertension and Heart Failure Treatment Revenue in Global (2016-2021)
  7.7.5 AstraZeneca Key News
7.8 Pfizer, Inc
  7.8.1 Pfizer, Inc Corporate Summary
  7.8.2 Pfizer, Inc Business Overview
  7.8.3 Pfizer, Inc Hypertension and Heart Failure Treatment Major Product Offerings
  7.8.4 Pfizer, Inc Hypertension and Heart Failure Treatment Revenue in Global (2016-2021)
  7.8.5 Pfizer, Inc Key News
7.9 Sanofi SA
  7.9.1 Sanofi SA Corporate Summary
  7.9.2 Sanofi SA Business Overview
  7.9.3 Sanofi SA Hypertension and Heart Failure Treatment Major Product Offerings
  7.9.4 Sanofi SA Hypertension and Heart Failure Treatment Revenue in Global (2016-2021)
  7.9.5 Sanofi SA Key News
7.10 Dr. Reddy's Laboratories
  7.10.1 Dr. Reddy's Laboratories Corporate Summary
  7.10.2 Dr. Reddy's Laboratories Business Overview
  7.10.3 Dr. Reddy's Laboratories Hypertension and Heart Failure Treatment Major Product Offerings
  7.10.4 Dr. Reddy's Laboratories Hypertension and Heart Failure Treatment Revenue in Global (2016-2021)
  7.10.5 Dr. Reddy's Laboratories Key News
7.11 Daiichi Sankyo Company Limited
  7.11.1 Daiichi Sankyo Company Limited Corporate Summary
  7.11.2 Daiichi Sankyo Company Limited Business Overview
  7.11.3 Daiichi Sankyo Company Limited Hypertension and Heart Failure Treatment Major Product Offerings
  7.11.4 Daiichi Sankyo Company Limited Hypertension and Heart Failure Treatment Revenue in Global (2016-2021)
  7.11.5 Daiichi Sankyo Company Limited Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hypertension and Heart Failure Treatment Market Opportunities & Trends in Global Market
Table 2. Hypertension and Heart Failure Treatment Market Drivers in Global Market
Table 3. Hypertension and Heart Failure Treatment Market Restraints in Global Market
Table 4. Key Players of Hypertension and Heart Failure Treatment in Global Market
Table 5. Top Hypertension and Heart Failure Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hypertension and Heart Failure Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hypertension and Heart Failure Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hypertension and Heart Failure Treatment Product Type
Table 9. List of Global Tier 1 Hypertension and Heart Failure Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hypertension and Heart Failure Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Hypertension and Heart Failure Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Hypertension and Heart Failure Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Hypertension and Heart Failure Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Hypertension and Heart Failure Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Hypertension and Heart Failure Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Hypertension and Heart Failure Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Menarini Group Corporate Summary
Table 31. Menarini Group Hypertension and Heart Failure Treatment Product Offerings
Table 32. Menarini Group Hypertension and Heart Failure Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Hypertension and Heart Failure Treatment Product Offerings
Table 35. Johnson & Johnson Hypertension and Heart Failure Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Lupin Corporate Summary
Table 37. Lupin Hypertension and Heart Failure Treatment Product Offerings
Table 38. Lupin Hypertension and Heart Failure Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Boehringer Ingelheim Corporate Summary
Table 40. Boehringer Ingelheim Hypertension and Heart Failure Treatment Product Offerings
Table 41. Boehringer Ingelheim Hypertension and Heart Failure Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Novartis Corporate Summary
Table 43. Novartis Hypertension and Heart Failure Treatment Product Offerings
Table 44. Novartis Hypertension and Heart Failure Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Merck & Co Corporate Summary
Table 46. Merck & Co Hypertension and Heart Failure Treatment Product Offerings
Table 47. Merck & Co Hypertension and Heart Failure Treatment Revenue (US$, Mn), (2016-2021)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Hypertension and Heart Failure Treatment Product Offerings
Table 50. AstraZeneca Hypertension and Heart Failure Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Pfizer, Inc Corporate Summary
Table 52. Pfizer, Inc Hypertension and Heart Failure Treatment Product Offerings
Table 53. Pfizer, Inc Hypertension and Heart Failure Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Sanofi SA Corporate Summary
Table 55. Sanofi SA Hypertension and Heart Failure Treatment Product Offerings
Table 56. Sanofi SA Hypertension and Heart Failure Treatment Revenue (US$, Mn), (2016-2021)
Table 57. Dr. Reddy's Laboratories Corporate Summary
Table 58. Dr. Reddy's Laboratories Hypertension and Heart Failure Treatment Product Offerings
Table 59. Dr. Reddy's Laboratories Hypertension and Heart Failure Treatment Revenue (US$, Mn), (2016-2021)
Table 60. Daiichi Sankyo Company Limited Corporate Summary
Table 61. Daiichi Sankyo Company Limited Hypertension and Heart Failure Treatment Product Offerings
Table 62. Daiichi Sankyo Company Limited Hypertension and Heart Failure Treatment Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Hypertension and Heart Failure Treatment Segment by Type
Figure 2. Hypertension and Heart Failure Treatment Segment by Application
Figure 3. Global Hypertension and Heart Failure Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hypertension and Heart Failure Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hypertension and Heart Failure Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hypertension and Heart Failure Treatment Revenue in 2020
Figure 8. By Type - Global Hypertension and Heart Failure Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Hypertension and Heart Failure Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Hypertension and Heart Failure Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Hypertension and Heart Failure Treatment Revenue Market Share, 2016-2027
Figure 12. US Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Hypertension and Heart Failure Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Hypertension and Heart Failure Treatment Revenue Market Share, 2016-2027
Figure 24. China Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Hypertension and Heart Failure Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Hypertension and Heart Failure Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Hypertension and Heart Failure Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Menarini Group Hypertension and Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Johnson & Johnson Hypertension and Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Lupin Hypertension and Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Boehringer Ingelheim Hypertension and Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Novartis Hypertension and Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Merck & Co Hypertension and Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. AstraZeneca Hypertension and Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Pfizer, Inc Hypertension and Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sanofi SA Hypertension and Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Dr. Reddy's Laboratories Hypertension and Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)